Sector & Market
Cytokinetics Shares Rise 4% on Bristol Update
Cytokinetics shares jumped 4% on Thursday, outperforming the Nasdaq Biotechnology Index’s 1% gain after Bristol’s ACACIA trial update.
Bank of America analysts note Bristol’s renewed commitment to non
